Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis

Dihydropyrimidine dehydrogenase (DPD) deficiency is associated with severe fluoropyrimidines-induced toxicity. As of September 2018, French recommendations call for screening for DPD deficiency by plasma uracil quantification prior to all fluoropyrimidine-based chemotherapy. A dose reduction of fluo...

Descripción completa

Detalles Bibliográficos
Autores principales: Laures, Nicolas, Konecki, Céline, Brugel, Mathias, Giffard, Anne-Lise, Abdelli, Naceur, Botsen, Damien, Carlier, Claire, Gozalo, Claire, Feliu, Catherine, Slimano, Florian, Djerada, Zoubir, Bouché, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610761/
https://www.ncbi.nlm.nih.gov/pubmed/36297556
http://dx.doi.org/10.3390/pharmaceutics14102119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610761/
https://www.ncbi.nlm.nih.gov/pubmed/36297556
http://dx.doi.org/10.3390/pharmaceutics14102119

Ejemplares similares